Screening for Primary Open-Angle Glaucoma
US Preventive Services Task Force, Carol M. Mangione, Michael J. Barry, Wanda K. Nicholson, Michael D. Cabana, David Chelmow, Tumaini R. Coker, Esa M. Davis, Katrina E Donahue, John W. Epling, Carlos Roberto Jaén, Alex H. Krist, Martha Kubik, Li Li, Gbenga Ogedegbe, Lori Pbert, John Ruiz, Melissa A. Simon, James Stevermer, John B. Wong
Abstract
Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).